Setolabo, together with our Singapore-based group company MEDBANK, recently participated in the international medical exhibition MEDICAL TAIWAN 2025, held in Taiwan.
This event provided us with a valuable opportunity to directly share with the people of Taiwan our ongoing research in genetic analysis and early cancer detection, which we have been developing in both Japan and Singapore. We were honored to receive a great deal of interest and thoughtful questions from many attendees.
Throughout the exhibition, we engaged in meaningful conversations with visitors to our booth and introduced Setolabo’s commitment to preventive healthcare and the philosophy behind our work. It was a great pleasure to connect with so many individuals who share our passion for early detection and proactive health management.
This exhibition marked a significant kickoff for our full-scale entry into the Taiwanese market. Moving forward, we plan to deepen collaborations with local partners in Taiwan as we advance toward clinical research and service implementation.
We sincerely thank everyone who visited our booth and all those who supported and assisted us. Your interest and encouragement inspire us to continue moving forward.